Relay Therapeutics, Inc. — Director's Dealing 2021

Mar 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2021-03-26

Reporting Person: Patel Sanjiv (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-16	Common Stock	G	150000	$0.00	Disposed	253082	Direct
2021-02-16	Common Stock	G	150000	$0.00	Acquired	674548	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-26	Stock Option (Right to Buy)	$34.25	A	325000	Acquired	2031-03-25	Common Stock (325000)	Direct

Footnotes

F1: Represents a transfer of securities by gift by the reporting person to The Patel Family Irrevocable Trust of 2019, an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after March 26, 2021, subject to the reporting person's continued employment through each vesting date.